Brain health
Imperial College London is working with Connectome Health to take brain monitoring technology into the consumer wellness market. The work aims to move brain health tracking beyond laboratories and clinics, using wearable-style technology to show how lifestyle may affect brain function. Connectome Health, co-founded by Imperial alumnus Dr Rufus Mitchell-Heggs, has developed a system that [...]
ReVision Implant has secured €4m in funding for its brain implant for severe blindness, as it moves from preclinical development towards first-in-human studies. The Belgian neurotechnology company said the oversubscribed funding round from private investors marks a key step in its transition from preclinical development to clinical exploration. The round included both existing investors and [...]
A living 'tumour-on-chip' is being developed to study glioblastoma and how drugs might best reach the aggressive brain cancer. The system is designed to mimic key features of the human brain inside a small laboratory device. Researchers hope it could offer fresh insight into how glioblastoma tumours grow and provide a more human-relevant way to [...]
An AI model detects several neurodegenerative diseases from a single blood sample, researchers at Lund University in Sweden say. Neurodegenerative diseases are conditions in which brain cells progressively deteriorate, such as Alzheimer’s and Parkinson’s. Different conditions can show similar symptoms, making them hard to distinguish, especially in the early stages of cognitive decline. A patient [...]
Scientists have made a significant step towards a blood test that detects brain tumours and monitors them in real time. The new test is 90 per cent accurate and could be used by GPs to pick up glioblastomas. It is also being expanded to include other types of brain tumour. The study, led by scientists [...]
A new Dravet syndrome drug has shown promising results in early clinical trials in children with the rare and hard-to-treat form of epilepsy. Dravet syndrome is a rare genetic disorder that causes severe epilepsy that is often resistant to treatment and can also lead to speech and developmental delays. Around 3,000 people in the UK [...]
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This "participation gap" means many life-saving drugs are tested on populations [...]
Brainomix has expanded its Series C round to £18.8m to scale its AI stroke and lung imaging platforms, with a focus on accelerating deployment in the US. The company added £4.8m to fund growth of its two core products. Brainomix 360 Stroke automates imaging assessment across the acute stroke pathway to support treatment and patient [...]
AI neuro platform nyra health has raised €20m in a Series A round to expand its AI-based neurological therapy services in Europe and the US. The Vienna-based company said the funding will be used to expand its technology platform in the DACH region, accelerate growth in the US and pursue its aim of setting a [...]
A study will test whether voice AI can flag multiple sclerosis earlier by analysing speech patterns. The study is led by Dr Timothy West, a neurologist at Intermountain Health’s Salt Lake Clinic in the US, with Canary Speech, a company specialising in vocal biomarker technology, and Intermountain Ventures. It is described as the [...]
